• First and only kidney product that does not deliver protein to the body.* Protein is toxic for people with chronic kidney disease and can worsen the condition.
  • Patented in 40 countries including all 38 member countries of the European Patent Organisation, Canada, and Japan. Pending United States.
  • Low-risk tool and market disruptor
    that delivers benefits to health that
    are not achieved with other strategies.
  • Extensive non-clinical and clinical assets support safety and effectiveness of the product technology.
  • Significant manufacturing partnerships with industry titans provide scale, reach, and infrastructure for global brand longevity.

* In a survey of medications and supplements commonly prescribed and used to help treat chronic kidney disease and support kidney health.

Help make a difference for millions of people in need. Become part of a great success story and join our equity crowdfunding campaign today. Visit wefunder.com/fluidlock

Connect With Us

HB Biotechnologies Corporation

P.O. Box 563 Village Station

New York, New York 10014 USA